Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York 11794-8651, USA.
J Biol Chem. 2010 Oct 8;285(41):31509-16. doi: 10.1074/jbc.M110.124891. Epub 2010 Aug 3.
The extracellular protease plasmin cleaves mouse MCP1 (monocyte chemoattractant protein 1) at lysine 104, releasing a 50-amino acid C-terminal domain. The cleavage event increases the chemotactic activity of MCP1 and, by doing so, promotes the progression of excitotoxic injury in the central nervous system in pathological settings. The mechanism through which the cleavage event enhances MCP1-mediated chemoattraction is unknown; to investigate it, we use wild-type and mutant forms of recombinant MCP1. Full-length MCP1 (FL-MCP1) is secreted by cells as a dimer or multimer. We show that a mutant truncated at the C terminus, K104Stop-MCP1, does not dimerize, revealing that the C terminus mediates the interaction. MCP1 interacts with the monocyte/microglia receptor CCR2. The interaction is critical to the function of MCP1 because CCR2(-/-) microglia do not undergo chemotaxis in response to MCP1 stimulation. We show that stimulation of microglia with FL-MCP1 or K104Stop-MCP1 triggers CCR2 internalization, whereas a mutant form unable to be cleaved at lysine 104 (K104A-MCP1) is relatively ineffective in this assay, suggesting that the C-terminal region interferes with the MCP1-CCR2 interaction. Moreover, FL-MCP1 and K104Stop-MCP1 stimulation leads to activation of Rac1, a small GTPase involved in cell migration. Conversely, MCP1-stimulated microglial migration is blocked by the Rac1 inhibitor, NSC23766, demonstrating the requirement for Rac1 effector pathways in this response. Taken together, we propose a model for MCP1 localization, activation, and function based on the initial presence and then removal of its C terminus, coupled with a requisite downstream signaling pathway from CCR2 stimulation to Rac1 activation.
细胞外蛋白酶纤溶酶在赖氨酸 104 处切割小鼠 MCP1(单核细胞趋化蛋白 1),释放出 50 个氨基酸的 C 末端结构域。该切割事件增加了 MCP1 的趋化活性,并由此促进了中枢神经系统在病理状态下兴奋性损伤的进展。切割事件增强 MCP1 介导的趋化作用的机制尚不清楚;为了研究它,我们使用了重组 MCP1 的野生型和突变型。全长 MCP1(FL-MCP1)作为二聚体或多聚体由细胞分泌。我们表明,在 C 末端截断的突变体 K104Stop-MCP1 不二聚化,表明 C 末端介导相互作用。MCP1 与单核细胞/小胶质细胞受体 CCR2 相互作用。这种相互作用对 MCP1 的功能至关重要,因为 CCR2(-/-)小胶质细胞在受到 MCP1 刺激时不会发生趋化作用。我们表明,用 FL-MCP1 或 K104Stop-MCP1 刺激小胶质细胞会触发 CCR2 内化,而不能在赖氨酸 104 处切割的突变体(K104A-MCP1)在该测定中相对无效,这表明 C 末端区域干扰了 MCP1-CCR2 相互作用。此外,FL-MCP1 和 K104Stop-MCP1 刺激导致 Rac1 的激活,Rac1 是一种参与细胞迁移的小 GTPase。相反,MCP1 刺激的小胶质细胞迁移被 Rac1 抑制剂 NSC23766 阻断,表明在这种反应中需要 Rac1 效应途径。综上所述,我们提出了一个基于 MCP1 定位、激活和功能的模型,该模型基于其 C 末端的初始存在和随后的去除,以及从 CCR2 刺激到 Rac1 激活的必需下游信号通路。